Company Overview of Pearl Therapeutics Inc.
Pearl Therapeutics Inc. focuses on developing combination therapies for the treatment of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma. The company focuses on developing metered dose inhaler (MDI) products, including a rapid-acting bronchodilator combination for the treatment of COPD. Pearl Therapeutics was founded in 2006 and is based in Redwood City, California with additional offices in Raleigh, North Carolina and Morristown, New Jersey. As of June 27, 2013, Pearl Therapeutics Inc. operates as a subsidiary of AstraZeneca PLC.
200 Saginaw Drive
Redwood City, CA 94063
Founded in 2006
Key Executives for Pearl Therapeutics Inc.
Pearl Therapeutics Inc. Key Developments
Similar Private Companies By Industry
|BIOPONS Inc.||United States|
|Mnemosyne Pharmaceuticals, Inc.||United States|
|HMGene, Inc.||United States|
|Edan Naturals LLC||United States|
|Reliv', Inc.||United States|
Recent Private Companies Transactions
June 10, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- San Francisco, CA | PwCPosted: Apr 12
- Missouri | AstellasPosted: Feb 21
Sponsored Financial Commentaries
To contact Pearl Therapeutics Inc., please visit www.pearltherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.